GlassScriptPhysician profile
Charles S Mccall
NPI 1316969561
$5,894.83
in general payments reported to CMS, 2019-2025
49 companies · $1,294 in 2025
The $1,294 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $436 · 2021: $802 · 2022: $913 · 2023: $986 · 2024: $906 · 2025: $1,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,151 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,151.40 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $738.65 | 2019-2024 | Xtandi, Veozah, Myrbetriq |
| Abbvie INC. | $695.93 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $596.78 | 2019-2024 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $465.13 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $350.14 | 2019-2023 | Erleada |
| Boston Scientific Corporation | $332.54 | 2019-2025 | Ams 700, Lithovue, Axonics |
| Accord Healthcare, INC. | $203.61 | 2025 | |
| Myriad Genetic Laboratories, INC. | $190.12 | 2022-2025 | Prolaris |
| Tolmar, INC. | $189.74 | 2023-2025 | Eligard, Jatenzo |
| Urovant Sciences INC | $152.84 | 2021-2022 | |
| Procept Biorobotics Corporation | $151.03 | 2024 | Aquabeam System |
| Caldera Medical, INC | $145.42 | 2023 | Desara |
| Endo USA, INC. | $129.30 | 2024-2025 | Xiaflex, Aveed |
| Coloplast Corp | $109.55 | 2019-2025 | Speedicath |
| Tolmar Pharmaceuticals, INC. | $108.74 | 2019-2022 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Mccall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.